The impact of NETosis on hematological malignancies as a promising therapeutic target

The impact of NETosis on hematological malignancies as a promising therapeutic target

Bibliographic Details
Main Author:	Duygu Aydemir
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Series:	Frontiers in Hematology
Subjects:	NEtosis NET multiple myeloma lymphoma leukemia blood cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/frhem.2024.1377806/full

Similar Items

TIGIT: A promising target to overcome the barrier of immunotherapy in hematological malignancies
by: Shenhe Jin, et al.
Published: (2022-12-01)

Extracellular Vesicles in Hematological Malignancies: From Biomarkers to Therapeutic Tools
by: Jihane Khalife, et al.
Published: (2020-12-01)

Molecular mechanisms and therapeutic target of NETosis in diseases
by: Jiayu Huang, et al.
Published: (2022-09-01)

Radiotheranostic Agents in Hematological Malignancies
by: Jo Caers, et al.
Published: (2022-07-01)

Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021-08-01)

Semaphorins and Their Receptors in Hematological Malignancies
by: Li Wei, et al.
Published: (2019-05-01)

Stem cell transplantation for hematologic malignancies /
by: Soiffer, Robert J.
Published: (2004)

NLRP3-Induced NETosis: A Potential Therapeutic Target for Ischemic Thrombotic Diseases?
by: Rahul Kumar, et al.
Published: (2023-11-01)

Netosis as a bridge between inflammation and liver cell injury
by: Anna Rycyk, et al.
Published: (2019-01-01)

Netosis as a bridge between inflammation and liver cell injury
by: Anna Rycyk, et al.
Published: (2019-01-01)

Role of the gut microbiota in hematologic cancer
by: Patricia Guevara-Ramírez, et al.
Published: (2023-08-01)

NETosis as an oncologic therapeutic target: a mini review
by: Sarah Jaboury, et al.
Published: (2023-04-01)

The Pattern of Hematological Malignancies at Al-Gamhouria Teaching Hospital, Aden, Yemen, from 2008 to 2010
by: Gamal Abdul Hamid
Published: (2012-12-01)

Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies
by: Paulina Biniecka, et al.
Published: (2023-02-01)

Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
by: Andrea Gaetano Allegra, et al.
Published: (2020-11-01)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
by: Rong Fan, et al.
Published: (2022-10-01)

Vital NETosis vs. suicidal NETosis during normal pregnancy and preeclampsia
by: Florence Guillotin, et al.
Published: (2023-01-01)

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies
by: Yutong Xie, et al.
Published: (2022-07-01)

Chromosome Territories in Hematological Malignancies
by: Matheus Fabiao de Lima, et al.
Published: (2022-04-01)

Microbiota and Hematological Diseases
by: Guido D'Angelo
Published: (2022-07-01)

Regulating NETosis: Increasing pH Promotes NADPH Oxidase-Dependent NETosis
by: Meraj A. Khan, et al.
Published: (2018-02-01)

Action Mechanism of Metformin and Its Application in Hematological Malignancy Treatments: A Review
by: Yi Zhang, et al.
Published: (2023-01-01)

NETosis-Forming Ability of Neutrophils in Patients with Limited and Disseminated Tuberculous Lesions
by: A. V. Mordyk, et al.
Published: (2023-07-01)

Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview
by: Alessandro Barbato, et al.
Published: (2020-12-01)

COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study
by: Xuejun Alice Wang, et al.
Published: (2021-10-01)

Metformin - its anti-cancer effects in hematologic malignancies
by: Monika Podhorecka
Published: (2021-02-01)

P2X7 Receptor in Hematological Malignancies
by: Elena De Marchi, et al.
Published: (2021-03-01)

Identifying PTAFR as a hub gene in atherosclerosis: implications for NETosis and disease progression
by: Chaowen Ye, et al.
Published: (2024-12-01)

Short-Term Fever-Range Hyperthermia Accelerates NETosis and Reduces Pro-inflammatory Cytokine Secretion by Human Neutrophils
by: Irene A. Keitelman, et al.
Published: (2019-10-01)

ROLE OF POLYMORPHISMS OF TOLL-LIKE RECEPTORS SIGNALING PATHWAY GENES IN THE DEVELOPMENT OF HEMATOLOGICAL MALIGNANCIES
by: E. L. Nazarova, et al.
Published: (2017-09-01)

NETosis in lupus nephritis
by: Tatiana M. Reshetnyak, et al.
Published: (2024-06-01)

Clinical application of CAR-T cells in treatment of hematologic malignancies
by: ZHANG Xi, et al.
Published: (2019-12-01)

The Role of Machine Learning in the Most Common Hematological Malignancies: A Narrative Review
by: Teresa Perillo, et al.
Published: (2024-09-01)

Editorial: Epidemiological trends in hematological malignancies
by: Marcos de Lima, et al.
Published: (2023-02-01)

Editorial: Case reports in hematological malignancies: 2022
by: Ahmad Antar, et al.
Published: (2023-08-01)

Prognostic Role of Blood NETosis in the Progression of Head and Neck Cancer
by: Anna Sophie Decker, et al.
Published: (2019-08-01)

NETosis: an emerging therapeutic target in renal diseases
by: Márk Juha, et al.
Published: (2023-09-01)

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
by: Marcos de Lima, et al.
Published: (2024-08-01)

One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
by: Ondrej Šušol, et al.
Published: (2024-12-01)

COEXISTENCE OF RENAL CELL CARCINOMA AND HEMATOLOGICAL MALIGNANCIES
by: Gokhan Sargin, et al.
Published: (2014-08-01)